The REQUITE Animation is now available in 6 languages. This animation produced by Animating Science in close collaboration with the REQUITE dissemination working group shows why we founded the REQUITE project.
Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
Het doel van deze internationale studie is het voorspellen welke patiënten een verhoogde kans hebben op bijwerkingen na radiotherapie (=bestraling)
The REQUITE Project is explained in this Animation produced by Animating Science in close collaboration with the REQUITE dissemination working group. The animation will be translated in Spanish, German, Italian, French and Dutch and these versions will be online as soon as possible.
We are very proud to show you the REQUITE Patient Video, subtitled in Spanish, French, German, Italian, Dutch and English.
This video highlights the goal of this multi-centre international study and the progress so far.
We would like to present our recent REQUITE video for Health Professionals:
The goal of the REQUITE project is to validate known predictors of adverse reactions and develop the statistical models to become clinically useful.
ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.
Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018
The annual congress of ESTRO will take place 26-30 April 2019 in Milan, Italy. ESTRO 38 will offer all professionals of oncology the chance to share knowledge, practice and advances in the field, within the ever warm and dynamic environment of the ESTRO meetings. ‘Targeting optimal care, together’ will be the theme of ESTRO 38 and through these few, however impactful words, the Scientific and organising committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty. The theme also represents our strength: we are all working towards a common goal for improved patient outcomes, and this will be expressed throughout the scientific programme... See for more information the website